EBIT: Income before interest and taxes.
ADC Therapeutics SA (ADCT) had EBIT of $-33.61M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$18.05M |
|
$-46.61M |
|
$2.51M |
|
$15.54M |
|
$51.67M |
|
$-33.61M |
|
$-12.14M |
|
$-45.76M |
|
$-45.76M |
|
$-45.92M |
|
$-46.61M |
|
$-46.61M |
|
$-45.92M |
|
|
EBIT |
$-33.61M |
$-32.77M |
|
82.55M |
|
82.55M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$290.21M |
|
$5.79M |
|
$17.76M |
|
$307.97M |
|
$62.98M |
|
$113.23M |
|
$439.43M |
|
$502.42M |
|
$-194.45M |
|
$-194.45M |
|
$-194.45M |
|
82.78M |
|
| Cash Flow Statement Financials | |
$-44.09M |
|
$-0.53M |
|
$0.36M |
|
$278.60M |
|
$234.28M |
|
$-44.31M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.61 |
|
-- |
|
-- |
|
-1.39 |
|
-0.58 |
|
86.10% |
|
-186.19% |
|
-186.19% |
|
-- |
|
-253.45% |
|
-258.16% |
|
$-44.63M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.16 |
|
0.78 |
|
115.59 |
|
23.97% |
|
23.97% |
|
-15.13% |
|
57.39% |
|
$-2.35 |
|
$-0.54 |
|
$-0.53 |
|